CGL
CBAY

Clarius Group LLC’s Cymabay Therapeutics CBAY Stock Holding History

Clarius Group LLC’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,938
Closed -$211K – 502
2023
Q4 		$211K Buy
+8,938
New +$159K 0.02% 441

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Clarius Group LLC's CBAY Position: Q1 2024 in Review

Clarius Group LLC sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 8,938 shares — an estimated $211K sold.

Clarius Group LLC first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $211K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Clarius Group LLC reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Clarius Group LLC sold 8,938 Cymabay Therapeutics shares in Q1 2024, an estimated $211K.
  • Clarius Group LLC first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
  • Clarius Group LLC's Cymabay Therapeutics position peaked at $211K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Clarius Group LLC's 13F filing for Q1 2024, filed 17 Apr 2024.